Relative Strength Chart Scholar Rock Holding Corporation

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
55.33 ^USD	-1.09%		-4.27%	+25.61%

09-02	Scholar Rock Receives FDA Fast Track Designation For Apitegromab Facioscapulohumeral Muscular Dystrophy Program As Participant Dosing Commences In Phase 2 FORGE Trial	CI
09-02	Scholar Rock Gets FDA Fast Track, Orphan Drug Designations for Muscular Disorder Drug	MT

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	SCHOLAR ROCK HOLDING CORPORATION	Bio Therapeutic Drugs	-1.09%	-4.27%	+25.61%	+76.15%	+51.96%	6.74B